Latest Unitaid Stories
GENEVA, May 20, 2015 /PRNewswire/ -- MPP signed 20 licensing agreements last year and is now working with 10 generic manufacturers on more than
First clinical trial to test a new all-oral regimen for extensively drug-resistant TB; Nix-TB is a critical step in the development of a universal treatment for all types of TB NEW
New funding supports the STAND trial and advances other new tools critical for tackling TB in the Asia-Pacific region and around the world NEW YORK, March 24, 2015 /PRNewswire-USNewswire/
Collaboration seeks to pull more sick children out of the shadows and into treatment for tuberculosis NEW YORK, March 24, 2015 /PRNewswire-USNewswire/ -- TB Alliance has announced
GENEVA, February 24, 2015 /PRNewswire/ -- Company joins five other MPP patent holders in efforts to improve HIV paediatric
TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years NEW YORK, Feb.
NEW YORK, Jan.
GENEVA, December 1, 2014 /PRNewswire/ -- Licence will support the work of the recently launched Paediatric HIV Treatment Initiative (PHTI) to Develop Better Adapted
Brock Will Lead Resource Development, Advocacy, Community Engagement Efforts in Support of Promising Research Pipeline NEW YORK, July 31, 2014 /PRNewswire-USNewswire/
Robertson Will Lead Initiatives to Accelerate Adoption of New TB Drug Regimens NEW YORK, July 31, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization with the
- A young chicken: also used as a pet name for children.